Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Development of Nasal Spray Pump Testing Method – V 2.0

Posted on By

Analytical Method Development: SOP for Development of Nasal Spray Pump Testing Method – V 2.0

Standard Operating Procedure for Nasal Spray Pump Testing Method Development in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/243/2025
Supersedes SOP/AMD/243/2022
Page No. Page 1 of 13
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define the procedure for developing and validating a method to evaluate the mechanical and functional performance of nasal spray pumps, including delivered

volume, actuation force, spray weight, and spray pattern.

2. Scope

This SOP applies to Analytical Method Development (AMD) personnel responsible for method development and quality assessment of nasal spray pumps used in metered-dose delivery systems.

3. Responsibilities

  • Analytical Scientist: Conducts testing of pump parameters and performs method optimization.
  • QC Analyst: Assists with calibration, data recording, and validation of pump performance.
  • QA Executive: Verifies data integrity, reviews validation report, and approves test method.
See also  Analytical Method Development: Dissolution Media Selection SOP - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring pump performance methods are scientifically justified and meet regulatory and product quality expectations.

5. Procedure

5.1 Test Parameters

  1. Delivered volume per actuation (µL)
  2. Spray weight per actuation (mg)
  3. Actuation force (N)
  4. Spray pattern and plume geometry

5.2 Delivered Volume Test

  1. Weigh empty collection vessel.
  2. Actuate nasal spray pump into vessel (e.g., 10 actuations).
  3. Weigh vessel again and calculate delivered volume using:

    Delivered Volume (µL) = (Final Weight − Initial Weight) / Number of Actuations × Density

5.3 Spray Weight Test

  1. Weigh each spray actuation individually into tared collection tube using high-precision balance.
  2. Perform for 10 doses and report average, min, max, and % RSD.

5.4 Actuation Force Measurement

  1. Use force gauge (digital/manual) to press spray pump vertically.
  2. Record peak force required to actuate (in Newtons).
  3. Ensure pump is tested in three repetitions and under standard conditions (e.g., 23°C ±2°C).

5.5 Spray Pattern and Plume Geometry

  1. Spray onto a clean paper placed 3 cm from nozzle.
  2. Capture image using a high-resolution camera.
  3. Use image analysis software to determine pattern symmetry and plume angle.
See also  Analytical Method Development: SOP for Establishing System Suitability Criteria - V 2.0

5.6 Acceptance Criteria

  1. Delivered volume within ±15% of target label claim.
  2. % RSD of spray weight ≤ 10% across 10 sprays.
  3. Actuation force between 20–80 N depending on design specification.
  4. Spray pattern should be symmetrical with defined plume angle (e.g., 30–60°).

5.7 Method Validation

  1. Validate for repeatability, robustness (vary temperature/humidity), and intermediate precision.
  2. Include pump-to-pump variability and replicate testing (minimum 3 units).

5.8 Documentation

  1. Maintain test logs, balance calibration, force gauge calibration, and image data in Annexures.
  2. Include detailed summary in Pump Test Validation Report.

6. Abbreviations

  • RSD: Relative Standard Deviation
  • HPLC: High Performance Liquid Chromatography
  • AMD: Analytical Method Development

7. Documents

  1. Spray Pump Test Log – Annexure-1
  2. Force Gauge Calibration Certificate – Annexure-2
  3. Pump Test Validation Report – Annexure-3

8. References

  • FDA Guidance for Nasal Spray and Inhalation Drug Products
  • USP <601>: Aerosols, Nasal Sprays, Metered-Dose Inhalers
  • ICH Q2(R1): Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Dr. Kavita Mehra Ravi Suryavanshi Sunita Reddy
Designation Formulation Scientist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Spray Pump Test Log

Sample ID Delivered Volume (µL) Actuation Force (N) Spray Weight (mg) RSD (%)
NSP-101 97.5 42 97.8 5.2

Annexure-2: Force Gauge Calibration Certificate

Gauge ID Calibration Date Calibrated By Next Due Date
FG-005 01/05/2025 QCLab Services 01/05/2026

Annexure-3: Pump Test Validation Report

Nasal spray pump tested for delivered volume, spray weight, actuation force, and plume geometry. All test results were within specification with consistent reproducibility. Method approved for commercial batch evaluation.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included plume geometry and force gauge calibration steps Annual SOP Review and Method Update Sunita Reddy
10/04/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Investigation of Out-of-Trend (OOT) Results - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight
Next Post: SOP Retraining After Observations or Deviations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version